Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics
Unnatural Products Inc. Collaboration will harness UNP’s AI enhanced macrocycle platform to drug historically “undruggable” targets SANTA CRUZ, Calif.,…